Related Experiment Videos
Contralateral pleural effusion during chemotherapy for tuberculous pleural effusion
1LRS Institute of Tuberculosis and Allied Diseases, Sri Aurobindo Marg, New Delhi-110030, India.
The Medical Journal of Malaysia
|February 24, 2001
Summary
A young woman experienced a worsening pleural effusion during tuberculosis treatment, a paradoxical reaction. Fortunately, continuing the same medication led to her recovery, highlighting this rare phenomenon in anti-tuberculosis therapy.
Area of Science:
- Medicine
- Pulmonology
- Infectious Diseases
Background:
- Tuberculosis (TB) treatment involves chemotherapy to combat Mycobacterium tuberculosis.
- Pleural effusion is a common complication of tuberculosis.
- Short-course chemotherapy is the standard treatment for tuberculous pleural effusion.
Observation:
- A 25-year-old female patient presented with a right pleural effusion.
- This occurred six weeks after initiating chemotherapy for a left-sided tuberculous pleural effusion.
- The patient's condition initially worsened despite ongoing treatment.
Findings:
- The patient's pleural effusion was presumed to be a paradoxical response to anti-tuberculosis treatment.
- Continuation of the same chemotherapy regimen resulted in clinical improvement.
- This suggests a complex immune reconstitution inflammatory syndrome (IRIS) or similar phenomenon.
Implications:
- Paradoxical reactions can occur during tuberculosis treatment, leading to temporary clinical deterioration.
- Recognition of paradoxical responses is crucial for appropriate patient management.
- Continued anti-tuberculosis therapy is often effective despite initial worsening, preventing treatment discontinuation.